Scientific basis for the efficacy of combined use of antirheumatic drugs against bone destruction in rheumatoid arthritis

• SUEMATSU Ayako

  Department of Cell Signaling, Graduate School, Tokyo Medical and Dental University and COE Program for Frontier Research on Molecular Destruction and Reconstruction of Tooth and Bone

• TAJIRI Yasuhito

  Department of Orthopaedic Surgery, Graduate School of Medicine, University of Tokyo

• NAKASHIMA Tomoki

  Department of Cell Signaling, Graduate School, Tokyo Medical and Dental University and COE Program for Frontier Research on Molecular Destruction and Reconstruction of Tooth and Bone

• TAKA Junko

  Department of Cell Signaling, Graduate School, Tokyo Medical and Dental University and COE Program for Frontier Research on Molecular Destruction and Reconstruction of Tooth and Bone

• OCHI Sae

  Department of Cell Signaling, Graduate School, Tokyo Medical and Dental University and COE Program for Frontier Research on Molecular Destruction and Reconstruction of Tooth and Bone

• ODA Hiromi

  Department of Orthopaedic Surgery, Saitama Medical University

• NAKAMURA Kozo

  Department of Orthopaedic Surgery, Graduate School of Medicine, University of Tokyo

• TANAKA Sakae

  Department of Orthopaedic Surgery, Graduate School of Medicine, University of Tokyo

• TAKAYANAGI Hiroshi

  Department of Cell Signaling, Graduate School, Tokyo Medical and Dental University and COE Program for Frontier Research on Molecular Destruction and Reconstruction of Tooth and Bone

収録刊行物

• Modern rheumatology

  Modern rheumatology 17 (1), 17-23, 2007-02-01

キーワード

• Disease-modifying antirheumatic drugs (DMARDs)
• Nuclear factor of activated T cells (NFAT) c1
• Osteoclast
• Receptor activator of NF-κB ligand (RANKL)
• Rheumatoid arthritis (RA)

詳細情報

• CRID: 1572824500230326528
• NII論文ID: 10018733776
• NII書誌ID: AA1157187X
• ISSN: 14397595
• Web Site: https://search.jamas.or.jp/link/ui/2007193161
• 本文言語コード: en
• データソース種別:
  • CiNii Articles
  • KAKEN